CCHR Opposes Psychedelic Drug Approval; Concerns Raised Over Adverse Effects
What happened
The Citizens Commission on Human Rights International submitted comments to the Food and Drug Administration opposing the approval of psychedelic drugs for mental disorder or emotional distress. The submission warned that approving these drugs could introduce a new class of psychotropic drugs with a high potential for adverse effects, including aggression, psychosis, and violence.
From manilatimes.net
Why it matters
The opposition challenges the Food and Drug Administration’s regulatory path for psychedelic drugs. The comments argue that these substances are not a scientific answer to a mental health crisis and that long-term safety evidence is lacking.
From manilatimes.net
Who's involved
- Food and Drug AdministrationThe government agency receiving input on the potential therapeutic use of psychedelic drugs.
- National Institute on Drug AbuseA government agency that voiced warnings regarding hallucinogen effects alongside CCHR.
Keep exploring
The entities involved
-
Food and Drug Administration
government organization in Nonthaburi, Thailand
-
National Institute on Drug Abuse
branch of the National Institutes of Health in the United States
Nothing else this week.